Cahaba Pharmaceuticals

About:

Cahaba Pharmaceuticals develops novel therapeutics and supportive care products for cancer patients.

Website: http://www.cahabapharma.com

Description:

Cahaba Pharmaceuticals, LLC, a biotech company, focuses on the development of oncology therapeutics and supportive care products for cancer patients. Its products include 1uracil topical ointment, a dihydropyrimidine dehydrogenase inhibitor for the treatment of hand-foot syndrome; and triciribine phosphate monohydrate, a nucleoside analog inhibition of AKT, a key component of a signaling pathway to promote cancer cell growth and survival, and resistance to chemotherapy and radiotherapy. The company was founded in 2008 and is based in Princeton, New Jersey.

Total Funding Amount:

$1.79M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Princeton, New Jersey, United States

Founded Date:

2008-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2013-01-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai